Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Qiagen ( (QGEN) ) has shared an update.
Qiagen has disclosed a notification from the Dutch Authority for the Financial Markets indicating that Massachusetts Financial Services Company has built a substantial shareholding and voting position in the company. As of a transaction dated January 8, 2026, MFS and related entities hold a total capital interest of 7.77% and voting rights of 9.98% in Qiagen through a mix of direct and indirect holdings, signaling increased institutional investor engagement that may influence future corporate governance and shareholder dynamics.
The most recent analyst rating on (QGEN) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Qiagen N.V. is a Netherlands-based life sciences company listed in Frankfurt and on other major exchanges, providing molecular diagnostics and sample preparation technologies to clinical, pharmaceutical and research markets worldwide.
Average Trading Volume: 1,196,106
Technical Sentiment Signal: Strong Buy
Current Market Cap: $9.81B
For detailed information about QGEN stock, go to TipRanks’ Stock Analysis page.